The carbonic anhydrase IX inhibitor SLC-0111 sensitises cancer cells to conventional chemotherapy

• Hoofdauteurs: Elena Andreucci (Auteur), Jessica Ruzzolini (Auteur), Silvia Peppicelli (Auteur), Francesca Bianchini (Auteur), Anna Laurenzana (Auteur), Fabrizio Carta (Auteur), Claudiu T. Supuran (Auteur), Lido Calorini (Auteur)
• Formaat: Boek
• Gepubliceerd in: Taylor & Francis Group, 2019-01-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Drug combination represents one of the most accredited strategies of cancer therapy able to improve drug efficacy and possibly overcome drug resistance. Among the agents used to complement conventional chemotherapy, carbonic anhydrase IX (CAIX) inhibitors appear as one of the most suitable, as marke...